Observational study / 2016
Fasting less than 13 hours per night was linked to an increased risk of breast cancer recurrence in women with early-stage breast cancer.
Data from 2413 women in the Women's Healthy Eating and Living study were analyzed to examine associations between nightly fasting duration and cancer prognosis. Fasting less than 13 hours per night was associated with an increased risk of breast cancer recurrence compared with fasting 13 or more hours per night (HR, 1.36; 95% CI, 1.05-1.76). Nightly fasting under 13 hours was not significantly associated with breast cancer mortality (HR, 1.21; 95% CI, 0.91-1.60) or all-cause mortality (HR, 1.22; 95% CI, 0.95-1.56). Additionally, each 2-hour increase in nightly fasting duration was associated with significantly lower hemoglobin A1c levels and longer nighttime sleep duration.
Shows an association, not proof of cause and effect.
- Study type
- Prospective cohort study
- Who was studied
- 2413 women with early-stage breast cancer without diabetes mellitus (aged 27-70 years)
- What was measured
- Breast cancer recurrence, new primary breast tumors, breast cancer mortality, all-cause mortality, hemoglobin A1c, CRP, and sleep duration
THE PAPER
Prolonged Nightly Fasting and Breast Cancer Prognosis.
Marinac CR, Nelson SH, Breen CI, Hartman SJ, Natarajan L, Pierce JP, Flatt SW, Sears DD, Patterson RE. JAMA Oncol, 2016.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.